Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Plasmonic Enhancement of Selective Photonic Virus Inactivation.

Nazari M, Xi M, Lerch S, Alizadeh MH, Ettinger C, Akiyama H, Gillespie C, Gummuluru S, Erramilli S, Reinhard BM.

Sci Rep. 2017 Sep 20;7(1):11951. doi: 10.1038/s41598-017-12377-5.

2.

Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.

Scheepers C, Chowdhury S, Wright WS, Campbell CT, Garrett NJ, Abdool Karim Q, Abdool Karim SS, Moore PL, Gildersleeve JC, Morris L.

AIDS. 2017 Oct 23;31(16):2199-2209. doi: 10.1097/QAD.0000000000001643.

PMID:
28926408
3.

Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon.

Akiyama H, Ramirez NP, Gibson G, Kline C, Watkins S, Ambrose Z, Gummuluru S.

J Virol. 2017 Oct 13;91(21). pii: e00972-17. doi: 10.1128/JVI.00972-17. Print 2017 Nov 1.

PMID:
28794041
4.

Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture.

Ruedas JB, Ladner JT, Ettinger CR, Gummuluru S, Palacios G, Connor JH.

J Virol. 2017 Jul 12;91(15). pii: e00392-17. doi: 10.1128/JVI.00392-17. Print 2017 Aug 1.

PMID:
28539437
5.

Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.

Miller CM, Akiyama H, Agosto LM, Emery A, Ettinger CR, Swanstrom RI, Henderson AJ, Gummuluru S.

J Virol. 2017 Jun 9;91(13). pii: e00051-17. doi: 10.1128/JVI.00051-17. Print 2017 Jul 1.

PMID:
28424288
6.

Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1.

Hammonds JE, Beeman N, Ding L, Takushi S, Francis AC, Wang JJ, Melikyan GB, Spearman P.

PLoS Pathog. 2017 Jan 27;13(1):e1006181. doi: 10.1371/journal.ppat.1006181. eCollection 2017 Jan.

7.

Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.

Kijewski SDG, Akiyama H, Feizpour A, Miller CM, Ramirez NP, Reinhard BM, Gummuluru S.

Virology. 2016 Oct;497:328-336. doi: 10.1016/j.virol.2016.07.029. Epub 2016 Aug 11.

8.
9.

Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection.

Sewald X, Ladinsky MS, Uchil PD, Beloor J, Pi R, Herrmann C, Motamedi N, Murooka TT, Brehm MA, Greiner DL, Shultz LD, Mempel TR, Bjorkman PJ, Kumar P, Mothes W.

Science. 2015 Oct 30;350(6260):563-567. doi: 10.1126/science.aab2749. Epub 2015 Oct 1.

10.
11.

CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies.

Akiyama H, Ramirez NG, Gudheti MV, Gummuluru S.

PLoS Pathog. 2015 Mar 11;11(3):e1004751. doi: 10.1371/journal.ppat.1004751. eCollection 2015 Mar. Erratum in: PLoS Pathog. 2015 May;11(5):e1004916.

12.

Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users.

Etemad B, Gonzalez OA, White L, Laeyendecker O, Kirk GD, Mehta S, Sagar M.

Retrovirology. 2014 Nov 28;11:106. doi: 10.1186/s12977-014-0106-8.

13.

CD169-dependent cell-associated HIV-1 transmission: a driver of virus dissemination.

Gummuluru S, Pina Ramirez NG, Akiyama H.

J Infect Dis. 2014 Dec 15;210 Suppl 3:S641-7. doi: 10.1093/infdis/jiu442. Review.

14.

Quantifying lipid contents in enveloped virus particles with plasmonic nanoparticles.

Feizpour A, Yu X, Akiyama H, Miller CM, Edmans E, Gummuluru S, Reinhard BM.

Small. 2015 Apr;11(13):1592-602. doi: 10.1002/smll.201402184. Epub 2014 Nov 10.

15.

HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1.

Izquierdo-Useros N, Lorizate M, McLaren PJ, Telenti A, Kräusslich HG, Martinez-Picado J.

PLoS Pathog. 2014 Jul 17;10(7):e1004146. doi: 10.1371/journal.ppat.1004146. eCollection 2014 Jul. Review.

16.

Glycosphingolipid-functionalized nanoparticles recapitulate CD169-dependent HIV-1 uptake and trafficking in dendritic cells.

Yu X, Feizpour A, Ramirez NG, Wu L, Akiyama H, Xu F, Gummuluru S, Reinhard BM.

Nat Commun. 2014 Jun 20;5:4136. doi: 10.1038/ncomms5136.

17.

Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.

Akiyama H, Miller C, Patel HV, Hatch SC, Archer J, Ramirez NG, Gummuluru S.

J Virol. 2014 Aug;88(16):8813-25. doi: 10.1128/JVI.00992-14. Epub 2014 May 28.

18.

HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells.

Rinaldo CR.

Scientifica (Cairo). 2013;2013:164203. doi: 10.1155/2013/164203. Epub 2013 May 7. Review.

19.

Dendritic cells in progression and pathology of HIV infection.

Manches O, Frleta D, Bhardwaj N.

Trends Immunol. 2014 Mar;35(3):114-22. doi: 10.1016/j.it.2013.10.003. Epub 2013 Nov 15. Review.

20.

Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169.

Puryear WB, Akiyama H, Geer SD, Ramirez NP, Yu X, Reinhard BM, Gummuluru S.

PLoS Pathog. 2013;9(4):e1003291. doi: 10.1371/journal.ppat.1003291. Epub 2013 Apr 11.

Supplemental Content

Support Center